Figure 2.
Mean blood glucose concentrations in patients with T2DM after administration of lixisenatide or placebo.
Note: Republished with permission of American Diabetes Association, from Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitus, Lorenz et al., Diabetes, 2012,61; permission conveyed through Copyright Clearance Center, Inc.
Abbreviations: AUC, area under the curve; LS, least squares; QD, once daily; SE, standard error; T2DM, type 2 diabetes mellitus; vs, versus.